Videos

Primary Myelofibrosis

CLL Case Review: IgHV-Unmutated Therapy Options

David S. Hong, MD, discusses the potential for other TRK inhibitors in the treatment landscape for patients with thyroid cancer after the approval of larotrectinib.

Andre Goy, MD, discusses a few combinations that are being investigated for the treatment of patients with relapsed/refractory mantle cell lymphoma.

High-Risk IgVH-Unmutated Chronic Lymphocytic Leukemia

Polycythemia Vera

Silvia C. Formenti, MD, discusses the advantages of radiation therapy in patients with lung cancer compared to other modalities.